This cutting edge Part I/II presentation series will introduce and carry the audience through the world of cutaneous T and B cell lymphomas. Learners will gather critical tips on assessment and diagnosis of patients suspected of cutaneous lymphoproliferative malignancy. Implementing and managing patients exposed to skin directed treatment options such as, topical corticosteroids, nitrogen mustard, phototherapy, and radiation will become strategic. A brief overview of systemic therapies will be included. Select case studies will be incorporated to solidify the teaching points. The ever so vital role of community engagement and advocacy in rare diseases such as CTCL and Cutaneous B cell Lymphoma will be intertwined.
Describe the physical examination features and symptom complex associated with patch/plaque/tumor/erythroderma associated with CTCL.
The learner will identify 2 key indications for delivery of skin directed and and systemic therapies in patients with persistent/progressive CTCL and will elaborate safety monitoring requirements.
Identify educational and advocacy resources for the CTCL patient population.
RN, MSN, DNC,
Programmatic Nurse Specialist,
RN, MSN, ANP,
Nurse Practitioner Dermatology and Cutaneous Oncology,
Dana Farber Cancer Institute
You must be logged in and own this session in order to